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ABSTRACT
White, Carla M. Audiologists’ Knowledge, Attitudes, and Practices Regarding
Patients with Systemic Lupus Erythematosus and Hearing Loss. Unpublished
Doctor of Audiology capstone research project, University of Northern
Colorado, 2020.

Patients diagnosed with systemic lupus erythematosus (SLE) have a moderate
to high risk of developing a sensorineural hearing loss. The purpose of this study was
to identify the knowledge, the degree of confidence, and the clinical practices of
audiologists and graduate students when providing audiological care to this
population. An opportunity for the respondents to share clinical experiences and
knowledge was also provided.
A sample of 77 respondents, 24 licensed audiologists and 53 graduate students,
represented that audiologists are generally aware of the disease and that SLE can cause
sensorineural hearing loss. Graduate students were more likely to learn about SLE
from personal relationships, while licensed audiologists first learned of SLE from
another health care professional. Outcomes also revealed that additional resources,
such as a clinical protocol and a list of SLE support groups, are needed and have been
requested by both respondent groups.
Both licensed audiologists and graduate students are knowledgeable with SLE
but are currently interested in clinical resources. There is an opportunity for additional
research to create a more formal and finite protocol to be utilized when an audiologist
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sees a patient with SLE. Further research should identify the appropriate actions an
audiologist must complete in order to ensure that sufficient long-term audiologic care
can be provided to patients diagnosed with systemic lupus erythematosus
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CHAPTER I
INTRODUCTION
Systemic lupus erythematosus (SLE), in short, can be described as increased
autoimmune activity. While healthy and typical autoimmune responses are designated
to attack foreign bodies and viruses present in the human body, healthy tissues,
organs, and other bodily systems are targeted by the overactive immune system. A
number of elements need to be taken in account when determining the cause of the
disease manifestation. Factors causing the presentation of SLE symptoms include
genetic makeup (Akirav et al., 2011; Anderson & Su, 2011), environmental events
(Davidson & Diamond, 2014), or a combination of these two factors. Gender and race
are known determinants: the majority of SLE patients are female, and higher rates of
African Americans are diagnosed with the disease (Dragin et al., 2017). Pubescent
development has a role in disease initiation; therefore, the majority of SLE patients are
age 20 or older (Bovo et al., 2006). These characteristics of SLE can make it
challenging for clinicians to confirm the presence of the disease.
Varying organ involvement is reported with each SLE patient, and the auditory
system is one of the vulnerable structures. Researchers have distinguished a number of
attributes associated with autoimmune-related hearing loss. If the patient does have
autoimmune involvement within the auditory system, a bilateral high-frequency
sensorineural hearing loss (SNHL) that is symmetrical in nature may develop.
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The majority of published work is quantitative in design. Researchers provide
recommendations to audiologists in the counseling and care for SLE patients
diagnosed with a hearing loss. For instance, these patients should pursue annual
hearing evaluations in order to monitor the hearing loss. What remains to be analyzed
is whether practicing audiologists are considering these recommendations. Research
that is qualitatively designed may render valuable information related to how
audiologists care and monitor SLE patients.
Statement of the Problem
The general understanding of the connection between hearing loss and
autoimmune responses related to SLE has been expanded upon through recent
research. What should be answered is what are the clinical methods and protocols used
by audiologists to evaluate and monitor autoimmune inner ear disease in SLE patients.
Are audiologists practicing in the United States aware of the heterogeneous nature of
SLE and that each SLE patient will have differing symptoms and secondary diagnoses
that develop due to the autoimmune disease? Do audiologists stress the importance of
annual hearing evaluations with this population due to unexpected flares or sudden
rise of symptoms? What is the timeline of events for a patient needing a medical
referral for SLE related hearing loss? How long is this process?
Rationale
The purpose of this study was to evaluate the knowledge, attitudes, and
practices of audiologists who see SLE patients for audiological evaluations. A survey
was developed and was composed of sections to evaluate knowledge, attitudes, and
practices. Additional demographic information was included, such as whether the
audiologist was currently licensed and how many years they had been providing
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audiological services. The purpose of the survey was to further inform best practices
in hearing health care provided to patients with SLE.
Research Questions
Q1

What are the knowledge, attitudes, and practice patterns of currently
practicing and experienced audiologists regarding patients with
systemic lupus erythematosus?

Q2

What are the knowledge, attitudes, and practice patterns of current
audiology graduate students regarding patients with systemic lupus
erythematosus?
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CHAPTER II
REVIEW OF THE LITERATURE
Systemic lupus erythematosus (SLE) is one of many autoimmune diseases that
have yet to be fully understood. While this disease is known for its impact on organs
such as the kidneys, skin, and heart, current research has identified the involvement
and pathophysiology of SLE on the auditory system. Over the past 30 years, multiple
groups of researchers have recognized the role of SLE in the onset of sensorineural
hearing loss (SNHL), tinnitus, and vertigo. Furthermore, the limited pharmacological
options intended to suppress the autoimmune activity of lupus have been found to
have ototoxic effects. The purpose of this literature review is to describe the degree
and prevalence of auditory impairment in SLE patients. The objective of this research
design is to identify the degree of knowledge and the therapy methods that are utilized
by audiologists within the United States.
Autoimmune Diseases
Autoimmune diseases have been studied for centuries; however, this type of
disease has yet to be fully understood. Due to the varying symptoms across patients,
thorough evaluation is required in order to confirm an autoimmune disease diagnosis.
Intensive testing includes multiple blood analyses to determine blood disorders and
antibody levels of the immune system, urine analysis to decide kidney involvement,
dermatological assessment to diagnose skin conditions, evaluation of reported pain
and soreness in the joints, and possible neurological examinations (Al-Sukaini et al.,
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2014). It is crucial that clinicians in multiple fields, including audiologists, are
informed of how this disease may impact the physiological and anatomy that falls
within their professional area of expertise.
Autoimmune disease is characterized as an immune response that presents as
an inflammatory response in either a concentrated area or within multiple systems of
the body (Davidson & Diamond, 2001). Diagnoses that fall within the category of
autoimmune diseases include Wedgener’s granulomatosis, rheumatoid arthritis, type II
diabetes mellitus, Sjogrens disease, Cogan syndrome, and Susac syndrome.
While the integrity and health of the body depend on the proper functioning of
the immune system, prolonged periods of increased immune activity can be
detrimental (Davidson & Diamond, 2014). As Davidson and Diamond (2001)
explained, a typical healthy immune response is initiated when the presence of foreign
bodies, such as an infection or bacteria, has been identified. Davidson and Diamond
stated that groups of T-cells, B cells, and monocytes attack the foreign bodies and
clear away the debris. In autoimmune diseases, areas of healthy tissues are damaged
by groups of overactive T-cells (Davidson & Diamond, 2001). In general, autoimmune
diseases are distinguished by the increased immune activity as well as damage of
healthy tissues.
Genetic studies have revealed that each disorder that falls under the
autoimmune disease umbrella has a genetic element (Akirav et al., 2011; Anderson &
Su, 2011). Deletion of a section of the autoimmune regulator (AIRE) gene or a defect
of the Fas gene can lead to the development of a form of autoimmunity (Fleisher et al.,
2001; Grodzicky & Elkon, 2002). Additionally, the lack of the Foxp3 gene, a T-cell
regulating gene, can result in an increased number of T-cells. In some cases, the
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failure to remove dead material after an immune response, leading to an accumulation
of material, causes an exaggerated immune response, a common feature of SLE
(Lewis & Botto, 2006; Pettigrew et al., 2009).
Additional research has confirmed theories that autoimmunity can also be the
result of environmental events (Davidson & Diamond, 2014). These alterations
include gum infections (periodontal disease) and smoking (Klareskog et al., 2011) as
well as ultraviolet light (Bijl & Kallenberg, 2006). Therefore, susceptibility to
autoimmune diseases is attributed to genetic predispositions, environmental events, or
a combination of the two (Davidson & Diamond, 2014).
The first signs of autoimmune disease development can occur at the age of 20
years or older (Bovo et al., 2006). Though uncommon, patients under the age of 20
have been diagnosed. Childhood-onset and juvenile-type SLE make up approximately
10% to 20% of the SLE population with the majority being diagnosed between 12 and
18 years of age (Silva et al., 2012). The majority of autoimmune diseases are more
prevalent in females than males, a finding that is indicative of sexual hormone
involvement (Davidson & Diamond, 2014). Studies have concluded that possessing
two X chromosomes increases the susceptibility to autoimmune diseases (SmithBouvier et al., 2008). This can be attributed to the greater number of genes located on
the X-chromosome that are responsible for immunological development (SmithBouvier et al., 2008).
Research completed by Dragin et al. (2017) reported that the expression of the
AIRE gene, responsible for managing autoimmunity, is decreased in females after
puberty. Further investigation suggests a possible relationship of the AIRE gene and
estrogen, suggesting that as estrogen levels increase, AIRE gene expression is
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suppressed (Dragin et al., 2017). Even with these recent findings, more research is
required to better understand the complex relationship of gender, genetics, and
autoimmune diseases.
Due to the complexity of these diseases, it is common to have a team of
clinicians work together and provide therapeutic options. While treatment and care is
typically provided at the discretion of a rheumatologist, patients diagnosed with
autoimmune diseases are likely to be seen by hematologists, vascular care
professionals, and audiologists. An overwhelming amount of evidence suggests that
select autoimmune diseases negatively impact the auditory system and cause different
degrees of hearing loss, affect the vestibular system, and are associated with a
prevalence of tinnitus. This type of knowledge can be used to educate audiologists
regarding the auditory structures that are impacted. As a result, an audiologist can
select therapeutic options and additions to the audiometric test battery to provide the
comprehensive medical surveillance and rehabilitative care this population requires.
Systemic Lupus Erythematosus
“Lupus” is the latin term for “wolf” and was first used by Pierre Louis Alpheé
Cazenave, a French physician, when he observed malar rashes in some SLE patients
that resembled the shape and color of the bite of a wolf. (Chabner, 2013).
“Erythematosus,” stemming from the root word “erythema,” is defined as redness of
the skin (Kim & Werth, 2014). As mentioned earlier, the malar rash, or malar
erythema, is a common feature of SLE and may be referred to as a “butterfly rash”
(Kim & Werth, 2014, p. 37).
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Diagnostic Criteria
The SLE is an autoimmune disease that is predominately diagnosed in the
young (Batuecas-Caletrío et al., 2013). Features of this disease can vary extensively
from patient to patient. Yu et al. (2014) published a review that discussed the most
recent update to the diagnostic criteria for SLE by the Systemic Lupus International
Collaborating Clinics (SLICC) in 2012. A diagnosis is determined if the individual
satisfies at least four features that fall into the following categories: abnormal
immunological features, hematologic disorder, renal disorders, serositis (inflammation
of serous tissues that surround the heart, lungs, and abdomen), symptoms affecting the
joints, and cutaneous disorders (Yu et al., 2014). According to the Rheumatology
Boston weighted criteria, common features of SLE include positive antinuclear
antibody (ANA) counts within the blood, cytopenia (reduced blood cell count),
arthritis, malar rash across the face, and photosensitivity (Costenbader et al., 2002).
These findings were based on the reported symptoms of SLE patients receiving care at
Massachusetts General Hospital Rheumatology Clinic (Costenbader et al., 2002). Due
to the considerable involvement of SLE throughout the body, the auditory system is at
risk of a magnified inflammatory response.
Prevalence
The Centers for Disease Control and Prevention have funded a number of
registries, as well as longitudinal research, with the intention of identifying the
prevalence of SLE in the United States in five regions: San Francisco County in
California, Manhattan in New York, Fulton and DeKalb counties in Georgia, and
Wayne and Washtenaw counties in Michigan (Dall’Era et al., 2017; Izmirly et al.,
2017; Lim et al., 2014; Somers et al., 2014). With these registries, the accuracy of the
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outcomes is questionable and possibly underestimated due to the exclusion of patients
within the Veterans Health Administration system (Izmirly et al., 2017), the limited
hospitals reviewed due to other facilities that declined to participate (Izmirly et al.,
2017), unidentified SLE cases (Somers et al., 2014), and the retrospective nature of the
research (Dall’Era et al., 2017; Lim et al., 2014; Somers et al., 2014).
Prevalence rates varied within each region. The highest value of 84.8 for every
100,000 individuals was reported in San Francisco County between the years 2007 and
2009 (Dall’Era et al., 2017). The prevalence rates were slightly lower in New York
with amounts at 62.2 for every 100,000 Manhattan citizens between 2007 and 2009
(Izmirly et al., 2017). Lim et al. (2014) reported rates in Georgia of 74.4 per 100,000
and 72.8 per 100,000 in Michigan. In all of these studies, a greater prevalence was
associated with women and individuals of African American background.
Other efforts have been devoted to the evaluation of SLE prevalence in the
United States. Helmick et al. (2008) used the 2003-2005 National Health Interview
Survey (NHIS) and determined that between 161,000 and 322,000 adults were living
with the disease at the time. Outcomes from the efforts of the Centers for Disease
Control and Prevention and NHIS provide a preliminary of the number of SLE
patients; however, further investigation is required to establish definite prevalence
rates.
To evaluate of the prevalence of hearing loss in SLE patients, Rahne et al.
(2017) compared 20 individuals with SLE to a control group that was matched for
both gender and age. The SLE patients were assessed according to duration of SLE,
what organs were impacted, the use of steroids over the time in which the disease had
been treated, and the use of immunosuppressive medications. The hearing evaluation
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completed with both participant groups included tympanometry, acoustic reflex
testing, pure-tone audiometry, sentence testing with speech perception and word
recognition, and distortion product otoacoustic emissions (OAEs). Pure-tone
audiometric testing resulted in higher rates of SNHL associated with the SLE group
compared to the control group. The results from the other tests in the audiometric test
battery were not significantly different between the two groups. Rahne et al.
interpreted these results to be the consequence of disease involvement affecting the
stria vascularis, spiral ganglion cells, or hair cells, or the result of microinfarctions of
temporal microvessels. From this research, it was estimated that there is a moderate to
high association of hearing loss with SLE (Rahne et al., 2017).
Temporal Bone Studies
Numerous auditory structures are impacted by SLE. Sone et al. (1999)
evaluated the structural integrity of the temporal bones from seven patients, ages 14 to
76 years, diagnosed with SLE. The presence of the stria vascularis, cochlear hair cells,
and ganglion cells was measured. The degree of loss of each auditory structure varied
by patient with case one having little involvement while cases three and seven showed
high losses of these structures from the cochlear base to the apex.
Kariya et al. (2016) examined a larger participant pool of temporal bones: 15
from SLE patients and an additional 17 bones that made up the age-matched control
group (between 14 and 76 years of age). Kariya et al. concluded that the amount of
stria vascularis tissue of all the cochlear turns was significantly reduced when
compared to normal temporal bones (p < 0.05). Significant findings were also present
with the degree of outer hair cell loss (p < 0.05). Inner hair cells were also impacted
yet this was not statistically significant (p < 0.05). Within this study, the most severe
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case was a 22-year-old woman with complete obliteration of cochlear structures such
as the organ of Corti, stria vascularis, and basilar membrane. These structures were
replaced with fibrous tissue left behind by the inflammatory response. In conclusion,
the invasive nature of SLE can result in the irreversible deterioration of multiple
auditory structures. Therefore, it is paramount that the audiologist promptly identifies
the hearing loss.
Hearing Loss Characteristics
Research completed in the late 1990s to today has identified varying degrees
and types of SNHL associated with SLE. Studies have been designed to recruit SLE
patients that are below the age in which presbycusis becomes a possible factor for the
onset of the hearing loss. When identifying the most common symptoms impacting the
auditory system, the researchers reported that prevalence of hearing loss due to SLE
ranged from 6% to 70% (Di Stadio & Ralli, 2017). There is little agreement across the
completed research studies about the range of frequencies that are impacted by SLE.
Disease Duration
Variable outcomes are also reported when disease duration is compared to the
degree of the hearing loss. The purpose of the study by Maciazczyk et al. (2011) was
to identify whether there was a relationship between these two factors. Thirty-seven
SLE patients were matched according to age and gender with a control group. The
SLE patient group was then divided into three groups according to disease duration:
five years or less, six to 10 years, and over 10 years. The mean age was 42.6 years for
the first group, 51.6 years for the second group, and 52.8 years for the third group. To
prevent the misinterpretation of hearing loss due to presbycusis rather than SLE, each
group was divided further into younger and older groups. Therefore, a total of six
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groups were evaluated. Maciazczyk et al. concluded that the duration of the disease
had a greater impact on audiometric thresholds than did age. This allows researchers
to rule out the role of presbycusis. Consequently, audiologists should be aware that
patients diagnosed with SLE early in their lives exhibit significantly decreased
auditory thresholds that are unrelated to presbycusis.
Frequencies
Di Stadio and Ralli (2017) completed a meta-analysis of the literature with
regard to SLE and the presence of SNHL. A prevalence rate of 65% for SNHL
affecting the higher frequencies, specifically 4000 and 8000 Hz was identified. Abbasi
et al. (2013) identified 12 of the 45 (26.7%) participants with SLE as having bilateral
high-frequency SNHL. Roverano et al. (2006) established that of 31 patients with a
mean age of 35 years, 66% had a bilateral SNHL in the higher frequencies.
Additionally, Maciazczyk et al. (2011) reported that 28.6% of the recruited SLE
patients had a high-frequency hearing loss when a standard audiometric battery was
completed. In conclusion, the onset of a high-frequency hearing loss is an apparent
characteristic of SNHL in individuals diagnosed with SLE.
Di Stadio and Ralli (2017) also reported that the second-most prevalent type of
SNHL (32%) occurred within the mid-frequencies, which affected 2000 and 3000 Hz.
Karatas et al. (2007) confirmed that 21% of the participants had a SNHL at 500, 1000,
and 2000 Hz. These outcomes support the proposition that autoimmune-related
hearing loss is not solely restricted to the higher frequencies.
Low-frequency SNHL occurred with a 3% prevalence rate in the published
literature (Di Stadio & Ralli, 2017). Rahne et al. (2017) evaluated 58 patients with
three autoimmune disorders, one of which included SLE. Results established that SLE
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patients were predisposed to the development of low-frequency SNHL. Karabulut et
al. (2010) suspected that the decreased audiometric thresholds in this frequency range
could be indicative of either endolymphatic or cochlear hydrops. Altogether, some
SLE patients may have a SNHL affecting the frequencies between 4000 and 8000 Hz,
while others have a SNHL impacting frequencies below 1000 Hz. This may be
attributed to the heterogenous nature of SLE in which each SLE patient can have
differing symptoms.
While results from multiple studies suggest that the SNHL is focused within a
specific range of frequencies, other studies have identified SNHL across a range of
frequencies. Andonopoulos et al. (1995) determined a significant decrease in auditory
thresholds at 125 and 500 Hz in the study group comprised of participants between the
ages 16 and 59 years. A second finding revealed a decrease in the higher frequencies
was observed in the group that was referred to as the young patients and incorporated
SLE patients between the ages of 16 and 29 years. Karabulut et al. (2010), after
completing pure-tone audiometry, found significantly decreased auditory thresholds at
250, 500, 1000, 2000 10,000, and 12,000 Hz. These findings indicate that both low
and high frequencies could be significantly impacted. In conclusion, a comprehensive
review of the literature demonstrates that high-frequency SNHLs are frequently
identified. However, reduced auditory thresholds have been identified in other
conventional audiometric frequency ranges.
Progressive Versus Static
Hearing Loss
An additional feature of SNHL in SLE patients that needs to be evaluated is
the time course: progressive or static. While this information is limited in its relation
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to systemic lupus, a few studies explored the longitudinal status of the hearing loss.
An early study by Sperling et al. (1996) associated a slowly progressive SNHL due to
the mechanisms of SLE. Cordeschi et al. (2004) had similar results with the use of
transient evoked otoacoustic emissions (TEOAEs). In antithesis of these findings,
Maciazczyk et al. (2011) determined that the hearing losss were static and not
susceptible to further decline.
Sudden Sensorineural
Hearing Loss
The SNHL with a sudden onset is a possible, but uncommon, event associated
with SLE. In a number of patient cases, the sudden hearing loss was the initial
symptom of SLE (Green & Miller, 2001; Kastanioudakis et al., 2002). Lin et al.
(2013) identified greater incidence rates of sudden SNHL in SLE patients when
compared to participants without the autoimmune disease. Furthermore, SLE patients
over the age of 35 years had a greater incidence of sudden SNHL (Lin et al., 2013).
Researchers have been aware of this feature of hearing loss associated with
SLE since the 1990s. One theory supporting the sudden onset includes a condition that
is frequently comorbid with SLE: antiphospholipid syndrome (APS). The APS is
known to cause microthrombosis of the stria vascularis (Hisashi et al., 1993). A
second theory states that the activity of the autoimmune antibodies can result in the
diminished numbers of inner ear proteins (Suzuki et al., 1997).
An additional feature to note is whether the patient with SLE has any comorbid
conditions, such as rheumatoid arthritis. Xie et al. (2019) focused on the likelihood of
recovery from a sudden SNHL in patients with both SLE and rheumatoid arthritis.
Findings suggest that the prognosis of this particular set of patients was low and that
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there was a low likelihood that hearing sensitivity would recover. Riera et al. (2019)
identified the same outcome in patients with SLE and APS. Overall, the additional
comorbidities can result in a poorer prognosis in terms of sudden SNHL.
While the incidence is not high, the sudden onset of SNHL should be
recognized as a potential feature in an SLE case. In addition, if a sudden SNHL is
confirmed in a patient, the audiologist and otolaryngologist must rule out the
likelihood of autoimmunity as the cause of the hearing loss. Lin et al. (2013)
recommended that SLE patients should have regular evaluations for the early
determination of autoimmune-related sudden SNHL.
Bilateral Versus Unilateral
Hearing Loss
Within the literature, studies have explored whether SNHL in SLE manifests
predominately as a bilateral loss or as a unilateral loss. The majority of published work
has identified the prevalence of bilateral SNHL within this specific population (Abbasi
et al., 2013; Kastanioudakis et al., 2002; Maciazczyk et al., 2011; Roverano et al.,
2006; Sperling et al., 1996). However, a number of research studies have identified
cases of both bilateral and unilateral SNHL (Gomides et al., 2007; Karatas et al.,
2007). Gomides et al. (2007) identified three patients with a bilateral loss and four
patients with unilateral losses, approximately 57% of the identified participants.
Similar findings were found by Karatas et al. (2007); three individuals were identified
with a unilateral SNHL and three other individuals with bilateral SNHL. Overall,
evidence confirms that a bilateral SNHL is more likely to manifest; however, an
audiologist should anticipate the possibility of identifying either a unilateral or
bilateral SNHL caused by the autoimmune response related to SLE.
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Symmetry
The symmetry of a bilateral hearing loss attributed to SLE should be
considered. Published literature has focused on the identification of the frequencies
impacted and provides only a limited amount of information regarding whether the
hearing losses were symmetrical or asymmetrical. Early findings from Sperling et al.
(1996) concluded that asymmetric hearing losses were prevalent in lupus patients.
Others have found contrasting results to Sperling et al. (1996). The 20 patients
identified by Roverano et al. (2006) with a SNHL loss were all symmetrical.
Additionally, both standard audiometric testing and auditory brainstem response
(ABR) testing by Maciazczyk et al. (2011) identified symmetrical bilateral losses in
the recruited participant group. From this analysis, it appears that there is greater
prevalence of symmetrical SNHL than asymmetrical SNHL in systemic lupus patients.
Hearing Loss Severity
The following parameters of hearing loss associated with SLE have been
identified: frequency and symmetry. The degree or severity of disease activity is an
additional feature that is utilized to anticipate a hearing loss. In the previous study,
Maciazczyk et al. (2011) evaluated the patients according to the severity of renal
conditions, central nervous system conditions, and antibody levels, all of which are
influenced by SLE severity. An audiometric evaluation consisting of pure-tone
audiometry, speech recognition testing, word recognition testing, tympanometry, and
auditory brainstem response testing was completed and results were compared to those
of a control group consisting of age-matched participants with normal hearing
sensitivity and no health conditions. The degree of the hearing loss and the severity of
the SLE were found not to be correlated. Therefore, the researchers established that
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greater organ involvement does not necessarily mean that a greater degree of hearing
loss will manifest.
Roverano et al. (2006) reported similar outcomes. The Systemic Lupus
Erythematosus Disease Activity Index was administered prior to completing
audiometric measures in order to quantify the disease activity of each patient. Of the
21 patients with a hearing loss, 11 reported little disease activity while the remaining
10 described persistent activity, experiencing a flare-up, or impairment caused by the
disease activity. Roverano et al. (2006) concluded that there was not a correlation
between disease activity and the presence of a hearing loss.
Numerous characteristics are associated with SNHL loss due to SLE. While
there is variability in the outcomes, audiologists can anticipate a number of features
yet still be vigilant of the possible dissimilarities. Bilateral, symmetrical, highfrequency sensorineural losses are likely to be the most common audiometric
configuration. However, the audiologist should be aware of disease involvement if a
loss in the mid or lower frequencies has been identified. Prior to the evaluation, the
audiologist should ask the patient when the first symptoms of the disease were
apparent. This is a useful additional piece of information that can be used by the
audiologist. This interpretation of the published work suggests that there is a common
model of hearing loss associated with SLE; however, audiologists should also be
conscientious of the diverse audiometric features that can occur.
Vertigo
Over the years, the connection between SLE and vertigo has become more
apparent. Karatas et al. (2007), with the use of electronystagmography (ENG), found
that out of the 19 patients reporting audiovestibular symptoms, eight of this subset
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experienced symptoms of vertigo. The ENG testing established that 50% of the SLE
patients had abnormal vestibular responses. Further evaluation identified the following
abnormalities: gaze nystagmus, abnormal optokinetic performance, and positional
nystagmus. Eleven of these 19 patients had poor caloric responses.
During this same period of time, Gomides et al. (2007), with the use of the
Systemic Lupus Erythematosus Disease Activity Index, identified that 31.1% of their
participants reported vertigo. This finding is significantly greater than the reports of
vertigo from the control group (6.7%). Batuecas-Caletrío et al. (2013) recruited 89
SLE patients and determined that a subset of this population is susceptible to
vestibular disorders. Peripheral vertigo was identified in eight patients and benign
paroxysmal positional vertigo in one patient.
Kariya et al. (2016) evaluated the pathogenesis of vertigo associate with SLE.
Fifteen temporal bones from patients with SLE were used to examine the integrity of
the hair cells within the vestibular system, specifically in the saccular macula, the
utricular macula, as well as within the cristae. When compared to the control group,
there was a significant decrease in the number of type I hair cells, afferent cells, in all
of the vestibular structures mentioned. However, there was not a significant difference
when type II hair cells, or efferent cells, were evaluated.
Tinnitus
The SLE patients have also reported the presence of tinnitus. When surveys
were administered to participants, Maciazczyk et al. (2011) determined that 40%
reported tinnitus. Furthermore, Karatas et al. (2007) identified nine individuals with
tinnitus out of the 19 patients reporting audiovestibular involvement. While the reports
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of tinnitus vary by patient, these studies indicate an association between tinnitus and
SLE.
Identification of Autoimmune-Related Hearing Loss
Standardized conventional pure-tone audiometry has a role in identifying the
degree and type of hearing loss in SLE patients; however, additional diagnostic
measures can be utilized to identify and monitor the progression of the hearing loss.
This includes the administration of OAEs and extended high-frequency audiometry
(EHFA). The following section will review the components of the standard
audiometric battery as well as OAEs and high-frequency audiometry; all of which will
aid the audiologist in the identification of secondary autoimmune inner ear disease due
to SLE.
Audiometric Test Battery
Otoscopy, immittance audiometry, pure-tone audiometry, and speech
recognition testing comprise the collection of tests that are administered within a
standard hearing evaluation. The purpose of otoscopy is to evaluate the condition of
the outer ear and identify foreign bodies or pathologies. Immittance audiometry
evaluates the integrity of the middle ear structures and measures the efficacy of how
sound is transmitted within the outer and middle ear regions. Together, otoscopy and
immittance audiometry provide early indications of possible conductive components.
Pure-tone audiometry is the subjective measurement of the transmission of
tones from the outer ear to the cortical pathways leading to the auditory cortex.
Auditory thresholds from 250 Hz to 8000 Hz are determined with the use of airconduction testing, using insert or supra-aural headphones, and bone-conduction
testing, with the utilization of a bone oscillator placed on the mastoid or forehead. If
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thresholds are found outside of normal limits in an adult, exceeding a 20 dB hearing
level, and conductive components are not apparent, this is evident of a pathology or
condition within the inner ear or the central nervous system. Electrophysiological
testing, such as ABR and electrocochleography, is completed to identify the
functionality of these anatomical regions but is not part of the standard audiometric
test battery.
Use of Otoacoustic Emissions
Numerous researchers have identified autoimmune-related hearing loss with
the utilization of transient evoked and distortion production OAEs. The purpose of
OAE testing is to evaluate the functionality and motility of the cochlear outer hair
cells (OHC). The anatomy of the organ of Corti permits the OHCs to move in a
fashion that results in additional movement of nearby anatomical structures, such as at
the basilar membrane, and is referred to as the electromotile response. This response
that is elicited from an external sound source causes a wave of energy to travel in a
distal direction from the cochlea and towards the external auditory meatus. Due to the
tonotopic organization of the cochlea, frequency specific information can be obtained
by using a stimulus tone located near the target frequency on the basilar membrane
(Glattke & Robinette, 2007).
The OAE testing is comprised of presenting a stimulus using a probe placed in
the ear canal. During the presentation of the stimulus in distortion product otoacoustic
emissions (DPOAE) testing, the miniscule cochlear response is measured
simultaneously. Individuals with normal hearing sensitivity have strong responses
indicating normal OHC motility; presence of the electrical potential of the stria
vascularis, the structure that supplies nutrients to the OHCs, and the absence of any
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conductive component that prohibits the transmission of auditory signals leading to
and from the cochlea. Abnormal or absent responses may indicate damage to the
OHCs, damage to the stria vascularis, or a conductive component such as impacted
cerumen and otitis media (Glattke & Robinette, 2007). Two types of OAEs have been
used to monitor autoimmune inner ear disease: TEOAEs and DPOAEs.
The frequencies that had decreased OAE responses varied according to the
type of autoimmune disease. Despite this variance, high frequencies were found to be
more susceptible. Karabulut et al. (2010) completed a study comparing 30 subjects
without SLE to 26 patients with SLE. The researchers concluded that patients with
SLE may have absent DPOAEs for frequencies at 750 and 6000 Hz and absent
TEOAEs at 2000 and 3000 Hz.
Larsen et al. (2015) obtained DPOAEs on rates with cochlear damage due to
induced autoimmune involvement. The researchers completed DPOAEs on rats with
cochlear damage due to autoimmune involvement. Absent responses were identified
from 2000 to 63000 Hz. Therefore, in a controlled setting, Larsen et al. demonstrated
that high-frequency regions of the cochlea were more susceptible to auditory damage
and impaired DPOAEs.
Use of OAEs may be able to provide audiologists with the initial identification
of auditory damage attributable to an abnormal autoimmune response in the cochlea.
Botelho et al. (2014) recommended that the use of distortion product OAEs would be
advantageous for monitoring early progression of the hearing loss. This method of
testing could be especially beneficial for audiologists who are providing care to a high
case load of patients. The use of OAEs provides a swift measurement of cochlear
damage in relation to the functionality of the OHCs.
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Use of Extended High-Frequency
Audiometry
The advantage of determining thresholds at frequencies above the conventional
pure-tone test frequencies (250 – 8000 Hz) includes early identification of a hearing
loss, especially with patients susceptible to ototoxic medications or with a history of
noise exposure (Valiente et al., 2016). The extended high frequencies include 9000 to
20000 Hz. Karabulut et al. (2010) published their findings after completing thorough
audiometric testing with 26 SLE patients matched with 30 healthy participants. The
objective of this study was to fill in the gap in the literature pertaining to the
knowledge of the mechanisms causing hearing loss in patients with SLE. Measures
included EHFA (250, 500, 1000, 2000, 4000, 6000, 8000, 10000, 12000, 14000, and
16000 Hz), which was accompanied by DPOAE and TEOAE testing. When the SLE
group and control group were compared according to pure-tone audiometry testing,
significant differences between the SLE and control groups were identified at 250,
500, 1000, 2000, 10000, and 12000 Hz (p < 0.05 significance). These findings indicate
that a SNHL can extend into the higher frequencies, specifically to 10000 and 12000
Hz.
Lasso de la Vega et al. (2017) measured pure-tone thresholds from 125 to 8000
Hz, followed by EHFA pure-tone audiometry (9000, 10000, 11200, 12500, 14000,
16000, and 18000 Hz. Presbycusis was controlled for by recruiting younger patients
(the mean age of the 55 participants was 41.5 years). Hearing thresholds obtained at
125-8000 Hz were compared to the EHFA that assessed 8000 to 18000 Hz. Findings
revealed the presence of a SNHL between 8000 Hz and 18000 Hz in 70% of the
patients. Significant threshold differences were identified at 10000, 11200, 12500,
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16000, and 18000 Hz when the SLE and healthy participants were compared. Overall,
it was determined that an extended high-frequency loss from 8,000 Hz to 18000 Hz
was 33.6 times greater to be identified than a hearing loss that can be identified with
traditional pure-tone audiometry testing. Lasso de la Vega et al. concluded their results
with the following statement:
These results suggest and recommend that audiological assessment should be
done not only with [pure tone average] but also [extended high-frequency
audiometry] in patients with SLE in order to diagnose a possible subclinical
hearing loss and modify the ongoing treatment or add a therapy to prevent a
possible progression of hearing loss. (p. 165)
Hearing loss associated with autoimmune inner ear disease hearing loss should
be monitored for a number of reasons. The first is to monitor the progression of the
hearing loss over time as disease duration increases and in collaboration with
physicians, select appropriate therapeutic options. Moreover, SLE patients should be
monitored due to the risk of ototoxic effects of the treatment medications, such as the
antimalarial drug hydroxychloroquine. The use of EHFA and OAEs allows the
audiologist to document sub-clinical auditory damage as well as identify the early
onset of the SNHL.
A suggested audiometric test battery for SLE patients needs to include the
standardized pure-tone air and bone audiometry, impedance audiometry, speech and
word recognition tests, as well as OAEs and EHFA. The addition of the OAEs and
EHFA at the initial evaluation would establish baseline thresholds that could be used
as a reference during the monitoring process. These measures may provide early
warning signs of threshold changes related to the autoimmune disease.
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Ototoxic Medications
Multiple medications are prescribed to patients with SLE, and medications
may be added depending on the secondary symptoms that accompany the disease.
Synthetic antimalarial medications such as hydroxychloroquine (Plaquenil) and
chloroquine (Aralen) are the primary drugs used to control the symptoms of SLE.
Patients are counseled to take the medication for the remainder of their lives. These
medications are also utilized in the treatment of rheumatoid arthritis and other
connective tissue disorders (Bortoli & Santiago, 2007). What is concerning is the
chemical relationship of these medications to quinine; both hydroxychloroquine and
chloroquine are subtypes of quinine (Rynes & Park, 1993). Exposure to quinine, also
used in the treatment of malaria, has been reported in patients diagnosed with SNHL,
vertigo, and tinnitus (Jung et al., 1993). The ototoxic effects of quinine have been
observed at the spiral ganglion neurons within the cochlea may also affect the mobility
of the outer hair cells resulting in a decreased electromotile response (Zheng et al.,
2001). At this time, toxic effects of quinine on the vestibular system have not been
substantiated.
One case of accidental overdose of hydroxychloroquine resulted in permanent
auditory and vestibular symptoms. Chansky and Werth (2017) reported an incident in
which a patient experienced bilateral tinnitus and ataxia as well as symptoms of
numbness in her arms and legs. Changes in hearing sensitivity were not noted.
The outcomes of several studies suggest that patients taking
hydroxychloroquine and chloroquine can develop a sensorineural hearing loss. The
earliest reported study was by Johansen and Gran (1998) who described the
development of a severe SNHL loss in two SLE patients who had undergone years of
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hydroxychloroquine drug therapy. Seckin et al. (2000) reported findings in which a
woman developed a SNHL after five months of hydroxychloroquine treatment for
rheumatoid arthritis. When hydroxychloroquine was prescribed as a drug therapy for a
patient with HIV, a moderate-severe sensorineural hearing loss developed (Khalili et
al., 2014). What is unique for this specific case is that when hydroxychloroquine
exposure was ceased, audiometric testing revealed improved thresholds and indicated
that for HIV patients, hearing loss may be reversible. While not commonly reported,
physicians should be aware of the potential ototoxicity of the prescribed medication,
especially due to the long-term treatment course.
The SLE patients are susceptible to SNHL due to progression of autoimmune
inner ear disease, as well as the potential ototoxicity from antimalarial medications
used to control the progression of SLE. This review suggests that audiologists should
complete a thorough case history of SLE patients, identifying whether patients have
been prescribed this class of medications and if so, the duration of the exposure. With
the possible association of hydroxychloroquine and chloroquine to ototoxicity,
audiologists should implement auditory and vestibular evaluations to monitor any
changes in hearing sensitivity or balance
Resources and Support Groups
The invasive nature of SLE in addition to multiple secondary disorders can be
tolling on the patient. Support groups for SLE patients are available in multiple
formats and offered across the United States. The Lupus Foundation of America has
17 chapters located in numerous states. Another national group is Molly’s Fund
Fighting Lupus which has chapters established in Oregon, Wyoming, Tennessee, and
Massachusetts. Innumerable support groups are accessible online as well via websites
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or Facebook. Lupus Warriors, a Facebook group, currently has 11,000 members and
serves as a location to ask lupus-related questions and ask for support throughout
difficult times. The website group Daily Strength currently has 874 members. The
individuals are comprised of SLE patients and family members of those with SLE.
Partnerships have been established to advance lupus research, such as the
Lupus Research Alliance. Located in New York City, the Lupus Research Institute
promotes opportunities for SLE patients to participant in ongoing research with a
focus on preventing, treating, and curing SLE. In June 2017, the Lupus Research
Alliance established an advocacy group that successfully supported the expansion of
funds for medical research on SLE. The opportunity to support other SLE patients and
participants in ongoing research has formed a community for both patients and family
members impacted by the disease. These resources assist patients recently diagnosed
with hearing loss and provide information about other patients with similar
experiences.
Future Research
Future research should be qualitative in design in order gain insight about the
experiences of practicing audiologists caring for SLE patients, as each case may be
different due to the nature of the disease. Investigation should be completed in order to
determine what resources audiologists rely on. Furthermore, with the rise of studies
evaluating the details and relationship between hearing loss and SLE, there is the
question of whether this information has been integrated into graduate school courses
and classes developed for audiologists to earn continuing education units. The current
study answered these questions in a qualitative manner.
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CHAPTER III
METHODS
The purpose of this chapter is to outline the steps of survey administration and
data collection. The survey was constructed to describe the knowledge, attitudes, and
practices of audiologists and audiology graduate students caring for patients with a
hearing loss induced by systemic lupus erythematosus (SLE). This qualitative survey
was intended to accumulate statements and information regarding the provision of
audiological care for SLE patients and further inform best clinical practice in the
future. Appendix A includes the Institutional Review Board approval of the survey
and the overall project from the University of Northern Colorado.
Development of the Survey Instrument
Four sections made up the survey: demographics, knowledge, attitudes, and
practices. The demographic questions developed for the audiologists inquired on the
period of time the participant had practiced in audiology, what setting in which the
participant was currently practicing in, and which state in the United States they were
currently located. For graduate students, demographic questions included the number
of years completed within the program, the number of years of supervised clinical
experience accumulated, whether they were currently working at an internship or
externship location, and the location of the educational institution.
Prior to the administration of the electronic survey, a small pilot study was
completed to ensure that the survey was functional and that the questions were clearly
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understood. The necessary modifications to questions were made after the trial period
and before electronic links were distributed to participants in the main study.
Participants
Two populations were invited to complete the survey (see Appendix B):
graduate students enrolled in an accredited doctor of audiology graduate program or a
doctor of philosophy graduate program in audiology, and licensed audiologists who
were currently practicing. Licensed audiologists were included who were employed
within a medical setting, speech and hearing clinic, corporate audiology group
practice, otolaryngologist office, government patient care facility (such as Veterans
Affairs or Indian Health Services), hospital, military setting, or private practice setting.
Additional inclusion criteria considered whether the practicing audiologist provided
direct patient care for an adult population. Audiologists were excluded who did not
have experience seeing patients, were retired, or who were working in the educational
field. Audiology graduate students had to be enrolled in an institution within the
United States and the practicing audiologists must have been licensed in the United
States.
Survey Instrument
The electronic survey was developed using the Qualtrics (Smith, 2005)
software. A number of strengths of this software include permitting the survey
developer to coordinate the order in which the questions were sequenced based upon
the responses submitted by the survey-taker. For instance, the question, “What best
describes your current role in audiology?” served to identify the two groups of
participants; practicing audiologists and graduate students. In relation to the response
provided, the survey used skip logic to guide students to specific questions relating to
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their academic experience, while certified practicing audiologists were directed to
questions regarding their clinical experience.
Fifty-three questions were developed and divided into four sections:
Demographics, Knowledge of Systemic Lupus Erythematosus, Attitudes Towards
Systemic Lupus Erythematosus, and Practices in the Audiological Care of Patients
with Systemic Lupus Erythematosus. Within the demographics portion, questions
were presented according to whether the participant identified as a graduate student or
a practicing audiologist. This was determined with the first question: “What best
describes your current role in the field of audiology?” One purpose of the
demographics section was to identify survey-takers who did not have a role in
audiology and practicing audiologists who had not worked in a medical setting; both
groups were directed to the end of the survey. Within the demographics portion, there
were five questions for graduate students to answer and eight, at most, for practicing
audiologists.
Sixteen questions made up the Knowledge of Systemic Lupus Erythematosus
section that both participant groups completed. A total of 13 questions were formatted
as forced-choice; three of these questions included text-boxes for the survey-taker to
elaborate on the response. Furthermore, two questions required that the participant to
select all of the options that applied to the statement presented.
The Attitudes Towards Systemic Lupus Erythematosus segment required
answers to nine questions. The section began with a true/false question regarding the
importance of referrals to otolaryngologists for SLE patients. This was then followed
by two questions regarding whether additional tests procedures should be included in
the test battery and which evaluations, from a provided list, should be included. A total
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of eight statements and questions were presented that required the survey-taker to use
a sliding scale to report an answer. Seven of these questions utilized a scale of strongly
disagree to strongly agree and one question that utilized a not confident to confident
scale.
The final section, Practices Associated with Systemic Lupus Erythematosus
was composed of a collection of questions regarding whether the participant had cared
for a patient with SLE, the referral process and what other professionals were typically
contacted, whether the clinic in which the participant currently practiced had a
protocol for these patients or other autoimmune disease patients, and open-ended
questions about the development of a protocol for working with SLE patients.
Sampling Methods
Survey promotion to both audiologists and audiology graduate students was
electronic and accessible through a number of resources. One method was to post a
brief description and survey link on audiology-related Facebook groups. These groups
included Audiology Antics and Anecdotes For All Hearing Professionals, SOUNDing
Board Hearing Healthcare Professionals, Academy of Doctors of Audiology, and
Student Academy of Doctors of Audiology. All of these Facebook pages have
practicing audiologists and audiology graduate student followers.
The survey was also promoted in the E-Newsletter SAAy Anything that is
published every month. This allowed the survey to be distributed directly to graduate
students.
Furthermore, the use of snowball sampling was used. After the audiologist or
the graduate student completed the survey, a final note encouraged the survey-taker to
share the survey link to colleagues and peers in order to promote snowball sampling.
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Qualtrics (Smith, 2005) was programmed to only accept one survey response from an
Internet protocol address to partially control for multiple responses to the same survey.
Descriptive Analysis
Qualtrics was utilized to collect and analyze the data. This software permits a
researcher to design an original survey tool as well as the ability to summarize and
collate the results collected from the survey. Question development can range in
format, including multiple-choice selections, text-box options, and a gap analysis
style. In order to determine the SLE knowledge of both graduate students and
practicing audiologists, the average number of questions correctly answered according
to each participant group was calculated. For the attitudes portion, the multiple-choice
questions were formatted to allow respondents to rate their answer from strongly
disagree to strongly agree. The scores were averaged within each participant group
and compared descriptively.
The goal of this analysis was to allow an interpretation of the results for both
closed-choice questions and open-ended questions. The intention was to allow both
respondent groups to provide details of particular experiences in caring for these
patients and to gauge the degree of confidence and knowledge in caring for this SLE
patient population
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CHAPTER IV
RESULTS
Respondent Characteristics
A total of 133 individuals responded to the survey; 32 respondents identified as
licensed audiologists and 86 as graduate students. The remaining 12 responses were
false starts in which the survey was started but the first question, asking if the
respondent was a licensed audiologist or graduate student, was not answered. Initial
survey-based exclusion criteria in the licensed audiologist section included both
whether the respondent had provided direct patient care after receiving their degree
and if the individual was currently practicing in the United States. In the end, two
respondents were excluded for not having experience with direct patient care. One
observation made when implementing this exclusion criteria was that when the
graduate students who answered no to the question “Have you read or heard about the
autoimmune disease systemic lupus erythematosus?” many of them (n = 19) stopped
the survey shortly afterwards, and they may not have realized the survey would still
record their responses to other questions.
Therefore, another consideration for analysis included the extent to which the
survey was submitted with full completion. This chapter is composed of the
information collected from the surveys in which the respondents answered all of the
questions: 47 questions for licensed audiologists and 43 questions for graduate
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students. This resulted in a total of 24 licensed audiologist and 53 graduate student
surveys (n = 77) used for analysis.
Demographics of Graduate
Students
The majority of respondents (n = 53) who identified as graduate students
reported that they were between their third and fourth year of the audiology doctoral
program (33.96%, n = 18), followed by those in between the second and third year
(24.53%, n = 13). Two to three years of clinical experience was the greatest amount
(5.85%, n = 19) reported, followed by three to four years (24.53%, n = 13). See Table
1 for additional training and experience outcomes. Furthermore, when asked whether
the externship had been started, 52.82% (n = 28) of the respondents had not started
this phase of the graduate program, while 47.17% (n = 25) reportedly were at an
externship site. This is considering the fact that some graduate students may start their
clinical experience at a different time compared to students enrolled in other graduate
programs.
Students were primarily in programs located in Colorado, South Dakota, and
Wisconsin. Other locations included North Carolina, Oregon, and Texas. Overall, the
respondents were completing programs in the Midwestern United States.
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Table 1
Program Status of Graduate Student Respondents

Status

<1 yr
%

1-<2 yrs
%

2-< yrs
%

3-<4 yrs
%

4-<5 yrs
%

5-<6 yrs
%

Yr in
program
(n = 53)

9.43
(n = 5)

16.98
(n = 9)

24.53
(n = 13)

33.96
(n = 18)

13.21
(n = 7)

1.89
(n = 1)

Number of
clinical yrs
(n = 53)

13.21
(n = 7)

15.09
(n = 8)

35.85
(n = 19)

24.53
(n = 13)

9.43
(n = 5)

1.89
(n = 1)

Demographics of Licensed Audiologists
When posed with the question of terminal degree, 20 individuals (83.33%)
reported to have a doctoral degree in audiology. Two individuals identified as having a
master’s of science (8.33%). Other degrees noted were one doctor of philosophy
(4.16%) and one doctor of education (4.16%).
The location of the licensed audiologists was predominately Colorado
(33.33%, n = 8) followed by Oregon (12.5%, n = 3) and North Carolina (12.5%, n =
3). Other locations to note were Texas (8.33%, n = 2), Minnesota (8.33%, n = 2), and
Alabama (4.17%, n = 1). Pennsylvania, Idaho, Utah, Kentucky, and Maryland were
also included with one individual from each.
Licensed audiology respondents identified predominately as having practiced
less than five years (46%, n = 11) followed by audiologists who have practiced for 21
to 30 years (13%, n = 5). The responses for the number of years in a medical setting
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were mainly under five years (52%, n = 12) and six to 10 years (26%, n = 6). When
asked whether the individual had practiced in a medical setting, most licensed
audiologists had this experience when they took the survey (95.83%, n = 23). All 24
respondents reported that they had provided some form of direct patient care after
graduation. See Figure 1 for further details.
The most common current audiology practice settings included direct patient
care in an ear, nose, and throat office (30%, n = 8) and private practice (22%, n = 6).
This question was formatted for the respondent to select all the options that currently
applied in the case that the respondent was working multiple part-time positions. One
individual selected other and elaborated that they were employed at a nursing facility
(4.17%) (see Figure 2).
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Figure 1
Number of Cumulative Years of Practice and Number of Years in a Medical Setting
Reported by AudiologistRrespondents
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Figure 2
Practice Setting of the Licensed Audiologists

Knowledge Outcomes
The remainder of this chapter is divided into three sections: knowledge,
attitudes, and practices. Both audiologists and graduate student responses are
separately integrated into the subsequent tables and figures. The knowledge section
begins with questions regarding pre-existing knowledge of systemic lupus
erythematosus (SLE) of both groups and followed by pre-existing knowledge of SLE
and hearing loss. Outcomes of questions concentrating on clinical audiologic features
of SLE and hearing loss are included at the end.
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Pre-existing Knowledge of Systemic
Lupus Erythematosus
When posed with the question regarding whether students and audiologists
were aware of SLE and SLE associated with hearing loss, more students reported
awareness of SLE associated with hearing loss over SLE itself. In comparison, the 20
audiologists (83.00%) who identified as having an awareness of SLE were also aware
of the diseases’ association with hearing loss. The majority of both respondent groups
had some degree of awareness regarding an association of SLE and hearing loss. A
summary of the details are provided in Table 2.

Table 2
Awareness of Systemic Lupus Erythematosus (SLE) and Awareness of SLE Related
Hearing Loss by Graduate Students and Audiologists

Knowledge of SLE

Graduate students
(n = 53)
%

Licensed audiologists
(n = 24)
%

Aware of SLE

60.38
(n = 32)

83.00
(n = 20)

Awareness of SLE and
hearing loss

69.81
(n = 37)

83.00
(n = 20)

After establishing whether the respondents had this pre-existing knowledge,
those who were knowledgeable of SLE were asked where they first learned of the
disease. As a result, the pool of affirmative responses (n = 52) was smaller than the
total number of respondents (n = 77). A total of 32 graduate students and 20 licensed
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audiologists were included and responses were spread across all sources of
information. Graduate students primarily had a personal relationship as their source of
initial knowledge at 21.88% (n = 7). Audiologists, on the other hand, initially learned
of SLE from providing care to a patient with 15% (n = 3) or from another health care
professional at 15% (n = 3). Graduate students also reported learning of SLE in high
school with 3.13% (n = 1), and one respondent reported having an autoimmune
disorder related to SLE at 3.13% (n = 1). For the licensed audiologists, one was
diagnosed with SLE (5%), another needed SLE to be ruled out as their own personal
medical condition (5%), and the third from their mother (5%); it was not noted
whether the mother was diagnosed with SLE. A summary is provided in Table 3.
For knowledge of hearing loss related to SLE, this was again directed to the
separated pool of 52 respondents. A total of 35.85% (n = 19) graduate students
reportedly learned of the association from a graduate school course. These courses
included standard medical audiology classes, such as medical aspects, pathologies of
hearing, and auditory and vestibular pathologies. One student (3.13%) reportedly had
a pediatric audiology class that covered this topic while another student (3.13%) had a
clinical problem-solving class that included SLE. A similiar outcome was also evident
with audiologists. Graduate school courses that were not the standard medical
audiology class included a case study in a practicum staffing course (see Table 4).
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Table 3
Sources of Systemic Lupus Erythematosus (SLE) Information Identified by Graduate
Students and Audiologists

Source of information

Graduate students
(n = 32)
%

Audiologists
(n = 20)
%

Total responses
(n = 52)
%

Electronic media

6.25
(n = 2)

0.00
(n = 0)

3.85
(n = 2)

From an audiology colleague

6.25
(n = 2)

10.00
(n = 2)

7.69
(n = 4)

From another health care
professional

9.38
(n = 3)

15.00
(n = 3)

11.54
(n = 6)

Graduate school course

18.75
(n = 6)

10.00
(n = 2)

15.39
(n = 8)

Peer reviewed journal

3.13
(n = 1)

0.00
(n = 0)

1.92
( n = 1)

Personal relationship

21. 88
(n = 7)

0.25
(n = 5)

23.07
(n = 12)

Print, books, newspaper,
magazine

3.13
(n = 1)

0.00
(n = 0)

1.92
(n =1 )

Providing care to a patient
with SLE

3.13
(n = 1)

15.00
(n = 3)

7.69
(n = 4)

Television

18.75
(n = 6)

10.00
(n = 2)

15.39
(n = 8)

Other

9.38
(n = 3)

15.00
(n = 3)

11.54
(n = 6)
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Table 4
How Respondents were First Aware of the Relationship of Hearing Loss to Systemic
Lupus Erythematosus (SLE)

Responses

Graduate students
(n = 53)
%

Audiologists
(n = 24)
%

Total
(n = 77)
%

Audiologic care to patient
with SLE

1.89
(n = 1)

16.67
(n = 4)

6.49
(n = 5)

Audiology colleague

11.32
(n = 6)

8.33
(n = 2)

10.39
(n = 8)

Electronic media/internet
source

5.66
(n = 3)

4.17
(n = 1)

5.19
(n = 5)

Graduate school course

35.85
(n = 19)

20.83
(n = 5)

31.17
(n = 24)

Healthcare professional

3.77%
(n=2)

4.17%
(n=1)

3.90%
(n=3)

Peer reviewed journal

1.89
(n = 1)

12.5
(n = 3)

5.19
(n = 4)

Personal relationship

1.89
(n = 1)

4.17
(n = 1)

2.60
(n = 2)

Print, books, newspapers,
magazine

0.00
(n = 0)

0.00
(n = 0)

0.00
(n = 0)

Television

1.89
(n = 1)

4.17
(n = 1)

2.60
(n = 2)

Were not aware

30.19
(n = 16)

16.67
(n = 4)

25.97
(n = 20)

Other

5.66
(n = 3)

8.33
(n = 2)

6.49
(n = 5)
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Figure 3 summarizes the sub-set of responses for when respondents first
became aware of SLE. Graduate students were generally aware of SLE for less than
five years as a predominant answer (63%, n = 20) which coincides with their years in
the degree program. For audiologists, 25% (n = 5) reported that it had been six to 10
years since they had first become aware of SLE and 25% (n = 5) selected that they
were unsure of the time frame.
Knowledge of Audiologic
Symptoms
The following section outlines how graduate students and licensed audiologists
were able to answer questions specifically regarding audiologic symptoms observed in
patients with SLE. Due to a survey design error that permitted the respondent to skip
the question, two questions were removed due to the high rate of skipped responses.
These questions included asking what the greatest degree of hearing loss tends to be in
patients with SLE and the question on whether the hearing loss tends to be progressive
or stable. Eight knowledge questions remained afterwards; Table 5 provides a
summary of these results in the context of correctness based on peer-reviewed
evidence in the literature (Chapter II).
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Figure 3
How Long Ago were Graduate Students and Licensed Audiologists First Aware of
Systemic Lupus Erythematosus (SLE)
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Table 5
Number of Correct Responses between Graduate Students and Licensed Audiologists

Response

% correct

Graduate students
(n = 46)

Licensed audiologists
(n = 24)

What type of hearing loss is
commonly associated with hearing
loss from SLE autoimmune
responses?

86.79
(n = 46)

87.5
(n = 21)

For patients with SLE, does the
hearing loss tend to be bilateral or
unilateral?

41.51
(n = 22)

37.5
(n = 9)

Do you believe that the duration of
SLE and the degree of hearing loss
are correlated? (e.g., the longer a
person has had SLE, the poorer the
hearing).

71.70
(n = 38)

62.5
(n = 15)

Can patients with SLE experience
vertigo that is attributed to the
presence of the autoimmune disease?

75.47
(n = 40)

70.83
(n = 17)

SLE is thought to arise in patients
from which of the following factors:

77.36
(n = 41)

66.67
(n = 16)

The following medications are used
in the treatment of SLE. Based on
your knowledge, which ones can be
ototoxic, if any? Selected choice

41.51
(n = 22)

37.5
(n = 9)

Note. SLE = systemic lupus erythematosus.
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Attitudes of Licensed Audiologists and
Audiology Graduate Students
Both groups were presented the question on whether additional audiological
tests should be added to the standard audiometric test battery. This is specific to the
situation in which a patient with SLE is being provided audiologic care. The majority
of both graduate students and audiologists (84.42%, n = 65) held the opinion that
additional tests should be included: 92.45% (n = 48) with graduate students and
70.83% (n = 17) with licensed audiologists.
Respondents were allowed to select multiple tests. Evaluation with an extended
high frequency audiometry (EHFA) and distortion product otoacoustic emissions
(DPOAEs), were common selections within both groups; however, a total of 28
graduate students (58.33%) selected EHFA more often than the eight audiologists
(47.09%). See Table 6 for the number of total responses associated with each test.
Figure 4 compares graduate student and audiologist responses from the Likert
scale questions regarding respondent attitudes. Neither graduate students nor
audiologist feel confident in their knowledge of SLE or their ability to counsel patients
with SLE. Audiologists and graduate students were neutral regarding whether they had
the resources to allow them to provide audiologic care to patients with SLE.

46

Table 6
Tests that Should be Added to the Standard Audiometric Battery for Patients Being
Monitored for Systemic Lupus Erythematosus (SLE)
Test

Graduate students
(n = 48)
%

Audiologists
(n = 17)
%

Total
(n = 65)
%

Acoustic reflex threshold

54.17
(n = 26)

58.82
(n = 10)

55.38
(n = 36)

Acoustic reflex decay

22.92
(n = 11)

23.53
(n = 4)

23.08
(n = 15)

APD Testing

2.08
(n = 1)

0.00
(n = 0)

1.54
(n = 1)

Click ABR

45.83
(n = 22)

29.41
(n = 5)

41.54
(n = 27)

DPOAEs

64.58
(n = 31)

82.35
(n = 14)

69.23
(n = 45)

ECohG

20.83
(n = 10)

17.65
(n = 3)

20.00
(n = 13)

Extended HFA

58.33
(n = 28)

47.09
(n = 8)

55.38
(n = 36)

Extended HF DPOAEs

39.58
(n = 19)

23.53
(n = 4)

35.38
(n = 23)

Immittance testing

25.00%
(n = 12)

11.76%
(n = 2)

21.54%
(n = 14)

Multi-frequency tympanometry

2.08
(n = 1)

0.00
(n = 0)

1.54
(n = 1)

Speech in noise

0.00
(n = 0)

11.76
(n = 2)

3.08
(n = 2)

TEOAEs

12.50
(n = 6)

11.76
(n = 2)

12.31
(n = 8)

VEMP

2.08
(n = 1)

0.00
(n = 0)

1.54
(n = 1)

VNG

4.17
(n = 2)

0.00
(n = 0)

3.08
(n = 2)

Wide-band reflectance

4.17
(n = 2)

0.00
(n = 0)

3.08
(n = 2)

Note. APD = auditory processing disorder, ABR = auditory brainsten response, DPOAEs = distortion product optoacoustic
emissions, ECohG = electrocochleography, HFA = high frequency audiometry, TEOAEs = transient evoked optoacoustic
emissions, VEMP = vestibular evoked myogenic potential, VNG = videonystagmography.
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Figure 4
Comparison of Mean Likert Scores between Graduate Students and Licensed
Audiologists.
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Both groups felt strongly that patients with SLE should be referred to
additional support groups and that doctor of audiology graduate students should have
access to materials on the disease and hearing loss. Both groups generally agreed that
patients undergoing pharmacologic treatment may fatigue easily during testing.
Clinical Practices for Systemic Lupus
Erythematosus Patients
The majority of both groups of respondents had not provided care to patients
with SLE. However, 92% (n = 19) of graduate students had no experience with SLE
patients, compared to 59% (n = 14) of audiologists. See Figure 5 for an in-depth
representation of their experiences.
The sub-set of respondents (n = 14) who had provided audiologic care to
patients with SLE differed with regard to how often hearing evaluations for patients
with SLE should be advised (see Table 7). Graduate students were equally distributed
between annually, every 6 months, and every 3 months (25%, n = 1). The audiologists
(70%, n = 7) were more likely to recommend annual evaluations. Twenty to 25% of
respondents for both groups acknowledged that annual evaluations were sufficient
unless changes in hearing were subjectively experienced by the patient.
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Figure 5
Estimated Number of Patients with Systemic Lupus Erythematosus (SLE) Who have
been Cared for with Licensed Audiologists and Graduate Students
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Table 7
Response Summary to the Survey Question “How Often Do You Recommend Patients
with Systemic Lupus Erythematosus to Have a Hearing Evaluation?”

Recommendation

Graduate students
(n = 4)
%

Audiologists
(n = 10)
%

Total
(n = 14)
%

Annually

25
(n = 1)

70
(n = 7)

57.14
(n = 8)

Every 6 months

25
(n = 1)

10
(n = 1)

14.29
(n = 2)

Every 3 months

25
(n = 1)

0
(n = 0)

7.14
(n = 1)

Every month

0
(n = 0)

0
(n = 0)

0.00
(n = 0)

Annually, sooner if
changes perceived

25
(n = 1)

20
(n = 2)

21.43
(n = 3)

Table 8 summarizes the additional tests that are given to patients with SLE. A
total of eight respondents contributed to this portion of the survey. It should be noted
that these audiometric tests are not widely used within the field of audiology.

51

Table 8
Additional Audiometric Rests Provided to Patients with Systemic Lupus
Erythematosus?

Recommendation

Graduate students
(n = 2)

Audiologists
(n = 6)

Total
(n = 8)

APD testing

(n = 1)

(n = 0)

(n = 1)

OAEs

(n = 0)

(n = 1)

(n = 1)

Speech in noise

(n = 0)

(n = 3)

(n = 3)

Tone decay

(n = 1)

(n = 0)

(n = 1)

My basic battery is PTA/PTB, speech
thresholds/word recognition,
DPOAEs, immittance...reflexes

(n = 0)

(n = 1)

(n = 1)

Decay, OAEs, ABR

(n = 0)

(n = 1)

(n = 1)

Other

Note. ABR = auditory brainstem response, APD = auditory processing disorder,
DPOAEs = distortion product optoacoustic emissions, OAEs = optoacoustic
emissions, PTA = pure tone average, PTB = pure tone baseline.

Patient referrals made by licensed audiologists were predominately going to
rheumatologists (23%, n = 6), (23%, n = 4) to family practice physicians, and (12%, n
= 4) to otolaryngologist. This was followed by an otologist referral (18%, n = 3) and
neurology with (18%, n = 3). Two graduate students had experience with referrals;
one referred a patient with SLE to neurology, while the other student reported making
a referral to rheumatology (see Figure 6).
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Figure 6
Summary of Referrals to Other Specialists Made by Audiology Graduate Students and
Audiologists

For the respondents who stated that a referral was not made, a follow up
question requested further detail for their response. The licensed audiologist stated that
there was already a team of providers in place and so no referral was necessary. This
response was also reported by one of the two graduate students. The second graduate
student had typed in an incoherent answer into the text box.
Two graduate students and two licensed audiologists stated that they use a
specific clinical protocol for patients with SLE; however, no contact information was
offered in order to learn more about the protocols (this was a voluntary question).
There appears to be a strong professional interest of graduate students (89.58%, n =
43) and licensed audiologists (95.00%, n = 19) of having a clinical protocol
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implemented for patient with SLE. This was also reflected in the question that allowed
the respondents to select all of the resources they believed would be beneficial to have
in the clinic followed by an SLE resource list (83.82%, n = 57). See Table 9 for further
details. Additionally, eight respondents (11.76%), four from the graduate student
group and four audiologists, reported having additional training or continuing
education in SLE.

Table 9
Summary of Types of Information that Would be Useful to Graduate Students and
Audiologists with Regard to Providing Audiologic Care to Patients with Systemic
Lupus Erythematosus (SLE)

Response

Graduate students
(n = 48)
%

Audiologists
(n = 20)
%

Total
(n = 68)
%

Clinical diagnostic and monitoring
protocol

89.58
(n = 43)

95.00
(n = 19)

91.18
(n = 62)

List of interdisciplinary team
members

81.25
(n = 39)

50.00
(n = 10)

72.06
(n = 49)

SLE resource list for the clinician

83.33%
(n = 43)

70%
(n = 14)

83.82%
(n = 57)

Support group contacts

85.42
(n = 41)

55
(n = 11)

76.47
(n = 52)

Contact info of specialists

0.00
(n = 0)

5.00
(n = 1)

5.00
(n = 1)

Signs and symptoms

0.00%
(n = 0)

5.00%
(n = 1)

5.00%
(n = 1)

Other
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Open-Ended Comments
The final question of the survey permitted the respondent to add questions or
comments regarding the content of the survey. The comments are transcribed below:
“Is this the same as plain old lupus” (graduate student)?
We do not see many of these patients . . . but when we do it is important to
know what evaluations to provide and be able to counsel these patients on the
disorder and its progression. Additionally, it is essential to begin rehabilitative
treatment ASAP [as soon as possible] and be able to explain why/how and
what will be necessary in the future. (licensed audiologist)
“Most rheumatologists do not know or inform their patients that Plaquenil is ototoxic
and worse for some patients than others and requires education and monitoring”
(licensed audiologist).
Is systemic lupus erythematosus a specific type of lupus, or is it the medical
name for lupus? I had to Google this. You could have put a brief explanation
of what SLE [systemic lupus erythematosus] is at the start of your survey to
clarify this point, but you didn’t. Also, you could have had more questions
with ‘I don’t know’ as possible answers, because without that option I had to
randomly choose something and I don't know how those guesses will bias your
statistical analysis. (licensed audiologist)
Not a comment about providing care to patients, but rather feedback on the
survey—You did not provide enough opportunity to respond “I don’t know.”
That may skew your results. When not provided the opportunity to respond “I
don’t know” I guessed. If the purpose of the study is to determine the state of
knowledge of currently practicing audiologists, without “I don’t know” as an
option, you may overestimate the awareness of this condition. It may also be
helpful for you to know whether someone practicing in a “medical setting” is
practicing in an adult focused facility, a pediatric focused facility or a facility
that provides services across the lifespan. Pediatric audiologists may not
encounter this condition. (licensed audiologist)
Summary
These outcomes have identified subject areas in which the respondents were
knowledgeable about SLE and areas where improvement can occur. The general
consensus is that audiologists and graduate students were aware of the disease and the
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potential that a hearing loss of an autoimmune basis can develop. However, when it
came to the concept of what additional services and monitoring this patient group may
require, respondents were unsure and hesitant of their approach. For instance,
respondents on average were more likely to disagree that they are confident in their
understanding of SLE. This was also seen in with the counseling aspect, that the
respondents were likely to disagree that they would be able to appropriately counsel
someone with SLE.
When the respondents were permitted to select what audiometric tests to add to
the standard test battery when a patient with SLE is seen for a hearing evaluation,
EHFA and DPOE were the tests that were selected the most. Another takeaway from
the responses is that a protocol is needed. When the provided the option, both groups
responded that it would be useful in the clinic. Other resources were also requested,
such as a resource list and a list of support groups, but the highest selected option was
to have a universal protocol available. Overall, according to the survey responses there
is an awareness of the disease but in terms of follow up, graduate students and
licensed audiologists use a variety of methods to provide care to this patient
population.
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CHAPTER V
DISCUSSION
Experience of Providing Care
One component of this research was to identify the knowledge of hearing loss
associated with systemic lupus erythematosus (SLE) within the groups of practicing
audiologists and audiology graduate students. Respondents of both groups were
generally aware of SLE and the relationship of SLE with hearing loss. Graduate
students were more likely to report having first learned of SLE from a personal
relationship. Practicing audiologists on the other hand reported learning of SLE from
another health care professional.
Only 31% of both groups combined reported that they first learned of hearing
loss associated with SLE from graduate school courses. Another factor to consider is
that this topic area is fairly new in the field of audiology, bearing in mind that the
majority of the published research on this topic has been within the past decade. For
instance, the most recent prevalence studies that were completed by the Centers for
Disease Control and Prevention were published between 2014 and 2017 (Dall’Era et
al., 2017; Izmirly et al., 2017; Lim et al., 2014; Somers et al., 2014).
Overall, this is representative that some audiologists and graduate students may
have to rely on first-hand clinical experiences or other healthcare providers to be
introduced to this topic. The respondents also reported a lack of confidence in
counseling patients with SLE. This may also relate back to the lack of formal training
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in the disorder. Audiology graduate programs may need to expand their course content
to include SLE as a relevant clinical pathology and equip audiologists to counsel SLE
patients.
As indicated by this current research study, 59% of licensed audiologists and
92% of graduate students do not have experience providing care to patients with SLE.
This is anticipated with graduate students, considering that these individuals are in the
early stages of their clinical experience. Approximately 40% of licensed audiologists,
on the other hand, did recall having this background. While it is not anticipated that
the audiologist will be presented with a specific case such as this on a regular basis,
the concern is that this may result in the clinician not taking necessary means of care
specific to this population because of the irregular exposure. Considering that there is
a moderate to high prevalence of hearing loss in patients with SLE, it is critical that
the audiologist have resources to refer to if the time comes around that the audiologist
sees a patient within this population (Rahne et al., 2017).
It was somewhat surprising in this digital era to note that electronic media,
peer reviewed journal articles, or other print resources such as books were not more
commonly flagged (~1%, n = 5) as an initial source on SLE. It was beyond the scope
of this research study to review available resources, but it may be useful to provide
links to existing resources on professional organization websites and publicize on
social media frequented by audiologists and audiology graduate students. An
abbreviated list of resources is available in Appendix C that an audiologist can utilize.
Seven questions regarding expected audiologic symptoms and hearing loss
characteristics were presented to determine the familiarity of graduate students and
licensed audiologists with this subject area. These questions were forced-choice and
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did not provide an “I don’t know” option. The purpose of this formatting was to
capture what direction the respondent was leaning towards. An answer key to these
questions has been included in Appendix D.
The majority of both groups were able to correctly identify that the hearing
loss tends to be sensory or neural; 86% with graduate students and 87% of licensed
audiologists that is displayed in Table 5. Similar outcomes were observed to the
questions focusing on disease duration and degree of hearing loss, that vertigo can be a
symptom, and whether SLE influence by genetic and environmental factors.
When it comes to these topic areas, audiologists and graduate students
generally have the right mindset; however, this does not directly reflect how confident
the respondents were in their selection. Reflecting on the outcomes of the sider scales
of the attitudes section, both groups believed that they did not have a high degree of
confidence with their knowledge and understanding of SLE as well as the confidence
in their skills to counsel a patient with SLE. As a consequence, the respondents were
able to perform well with a subset of these questions; however, their confidence may
be wavering.
The question on whether the hearing loss tends to be bilateral or unilateral
reflected that respondents tended to select the bilateral only option: 41% of graduate
students and 37% of licensed audiologists. Similar outcomes were associated with the
questions on the susceptibility of patients with SLE to develop a hearing loss and
correctly determining that hydroxychloroquine can be ototoxic. It appears that current
audiologic resources may need to provide greater focus on these topic areas.
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Need for Clinical Resources
There was an overwhelming consensus from both respondent groups that
additional SLE-related resources are needed in the clinic. There was an agreement
from both groups that they were not confident with their knowledge and understanding
of SLE.
Development of a Clinical Protocol
Graduate students and practicing audiologists agreed that a clinical diagnostic
and monitoring protocol would be desirable to guide the evaluation and care of
patients with SLE. At this time, a protocol or guideline addressing the audiologic care
of patients with SLE has not been developed by any professional organization (e.g.,
American Academy of Audiology or American Speech-Language Hearing
Association). Professional assessment and monitoring guidelines would result in a
peer-reviewed agreement of how this patient population should be cared for by
audiologists. The existence of a peer-reviewed clinical protocol or guideline would
provide an additional opportunity to educate audiologists and graduate students
regarding hearing loss in patients with SLE. The following sections address the
clinical components that might be integrated into the guideline.
Case History
The development of a protocol would not be absent of its challenges. Each
patient with SLE can vary in system-wide symptoms and variability is expected with
regard to auditory symptoms as well (Al-Sukaini et al., 2014). Furthermore, symptoms
can change over time, requiring that regular comprehensive updates on patient
symptoms to be updated at each visit.
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The case history portion of the protocol should be as comprehensive as
possible in the instance that symptoms change in the future. Questions should inquire
about the time of SLE diagnosis, considering that patients diagnosed with SLE early in
their lives exhibit significantly decreased auditory thresholds that are unrelated to
presbycusis (Maciazczyk et al., 2011).
Moreover, features of tinnitus should be recorded at this time, as this could
determine whether additional evaluations are needed. The research suggests that
tinnitus symptoms are prevalent in patients with SLE; therefore, it should be
documented as soon as possible (Karatas et al., 2007; Maciazczyk et al., 2011). With
research suggesting nearly half of patients with SLE experiencing bilateral tinnitus,
the audiologist should anticipate counseling the patient that the cause of the symptom
is related to their autoimmune disease (Maciazczyk et al., 2011).
Vertigo is also a common feature. The audiologist needs to anticipate
counseling the patient that the pathogenesis of the vertigo symptoms may be related to
their SLE. The temporal bone study completed by Kariya et al. (2016) have supported
this concept of disease vestibulotoxicity and Gomides et al. (2007) identified a rate of
31.1% of patients with SLE who were experiencing vestibular symptoms. As an
audiologist, the case history should incorporate questions addressing any current
vertigo features are experienced by the patient with SLE.
A case history question devoted to the identification of current medications
should also be included. This could come in the simple form of a checklist to allow the
audiologist to quickly review with the patient. A concerning finding from this present
research is that respondents of both groups were not aware of the ototoxic effect of
Plaquenil (Seckin et al., 2000). Incorporating a standard sub-set of questions related to
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Plaquenil administration to the protocol would allow the audiologist to keep in mind
of not only the immune factors at large, but also the potential need for ototoxicity
monitoring.
Respondents expressed the importance of knowing the interdisciplinary team
that is overseeing the patient. This is an additional section to be highlighted in the case
history intake. What is paramount is determining the rheumatologist treating the
patient, especially if the audiologist has concerns that need to be communicated to the
physician related to changes in auditory functioning, especially in the context of
ototoxicity.
Additions to the Standard
Audiometric Battery
An SLE clinical protocol not only should provide guidelines to case history
intake, an outline of the audiometric battery should also be included. The predominant
view from respondents in terms of evaluating patients with SLE supported the
inclusion of additional tests beyond the standard audiological test battery. A review of
the literature suggests that an SLE protocol should include the additional test
measurements of extended high-frequency audiometry (EHFA) and distortion product
otoacoustic emissions (DPOAEs) (Botelho et al., 2014; Lasso de la Vega et al., 2017).
Both of these tests permit the audiologist to identify early features of a sensorineural
hearing loss and document any sub-clinical auditory damage. Furthermore,
considering that the malarial pharmaceutical hydroxychloroquine or Plaquenil used
with patients with SLE has the potential of causing the hearing loss, especially in the
higher frequencies, these tests would offer the opportunity to monitor the patient in
terms of ototoxicity (Chansky & Werth, 2017; Seckin et al., 2000).
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Incorporating EHFA and DPOAEs would provide general information
regarding neural functioning and an additional diagnostic measure to use if changes in
hearing sensitivity occur. Published research has indicated that the hearing loss can
become worse over time (Cordeschi et al., 2004; Sperling et al., 1996). Reflecting on
the current published research, it is critical that clinicians within the audiology field
focus incorporate EHFA and DPOAEs specifically for this patient population.
Monitoring Schedule
Another challenge in the establishment of a clinical protocol would be
determining how often audiological evaluations should be repeated. The general
practice of audiologists and graduate students is to schedule annual hearing
evaluations. Having an annual schedule may be an appropriate method considering
that the patient may need to attend many other healthcare appointments in the context
of monitoring their health.
A review of the literature also indicates a lack of evidence supporting
fluctuating hearing loss associated with systemic lupus erythematosus (Di Stadio &
Ralli, 2017; Rahne et al., 2017). Therefore, the nature of the hearing loss tends to be
more progressive and unlikely for the thresholds to recover. As a result, the
audiologist can anticipate a more standardized monitoring protocol that does not have
to incorporate additional appointments in order to document the fluctuation.
Some respondents noted that they advise SLE patients to contact them for
earlier testing if the patient notes subjective changes in hearing or concerns about their
hearing arise before the routine annual test. In the case of sudden sensorineural
hearing loss (SNHL), additional hearing evaluations may need to be scheduled in
order to confirm the sudden hearing loss or to document the fluctuations in hearing
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sensitivity. The research suggests that patients with SLE have a higher rate of sudden
SNHL than individuals without the disease (Lin et al., 2013). Recent publications have
identified even higher rates of sudden SNHL in patients with SLE who also have
additional disorders, such as rheumatoid arthritis and antiphospholipid syndrome
(Riera et al., 2019; Xie et al., 2019).
Considering the association of sudden SNHL, SLE, and the presence of
comorbid diseases, the audiologist may need to have an active role in clinical team
providing the patient care. This may require the audiologist to collaborate with the
rheumatologist or primary care physician in order to determine the best monitoring
schedule. The monitoring schedule may also be impacted by insurance
recommendations and reimbursement or referral requirements as well.
Professional Consensus
A professional consensus is needed to generate an interdisciplinary clinical
protocol. The best approach is to have a team of rheumatologists, otolaryngologists or
otologists, and audiologists who have extensive experience in providing care to
patients with SLE collaborate on a peer-reviewed guideline. This will permit a more
finite step-by-step course of action and eliminate potential conflicting opinions
regarding patient care. This document may also inform insurance companies with
regard to coverage for audiological services.
Additional Resources
In addition to the development of a protocol, there were other requests from
the respondents to have a list of SLE support groups to provide to patients. Appendix
E includes a handout to provide to patients who express interest in finding online and
local resources. These resources also allow the audiologist to read patient stories and
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become connected to other medical professionals that support patients with SLE.
Appendix E provides a list of these groups, all of which have online resources. It is
encouraged to have the audiologist become familiar with whether there are in-person
resources within their general area, as the availability of this type of support varies
depending on where the patient resides geographically. It should be noted that there is
an opportunity for the protocol to recommend the audiologist to provide these
resources and serve as a reminder to the audiologist of the availability of this
information.
Furthermore, a brief list of relevant research articles has also been provided in
Appendix E as a starting point for audiologists and graduate students to learn
additional information. This is beneficial for audiologists who may have access to
PubMed or an alternative database. Appendix E also provides a table of other online
resources for an audiologist to become acquainted with SLE characteristics. A list of
research articles to have in the clinic was requested by the majority of respondents and
this appendix would also address the concern that audiologists and graduate students
know which resources to utilize. While the references section of this research provides
a comprehensive list of resources, this abbreviated list to have on hand in the clinic as
a guide may be advantageous as a quick resource. These resources and protocol are to
provide audiologists and audiology graduate students a set of materials so that they
may adequate care to a group of patients that can vary in audiologic symptoms.
Accessibility to New Research
A search of lupus on the frequently used resource for audiologist continuing
education credits, AudiologyOnline.com, determined that there are no current
publications or presentations regarding hearing loss and autoimmune diseases. On the
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other hand, a search of diabetes found four links; two of which were a series of
presentations outlining hearing loss in chronic disorders (which included diabetes).
There may be a benefit in the development of a similar presentation: An informational
compilation of autoimmune diseases associated with hearing loss that included SLE
and conditions such as Wegener’s granulomatosis, rheumatoid arthritis, Sjogren’s
disease, and Cogan syndrome. Again, taking into account that the SLE research is
relatively new, an electronic continuing education presentation that was easily
accessible would allow audiologists to keep up to date.
Initial Development of a Protocol
Appendix F outlines a very general protocol that can provide the initial
recommendations of audiologic care for a patient with SLE. Sections include what
questions to incorporate into the case history, what baseline audiometric battery
should be used, and what to keep in mind when determining a monitoring schedule.
Again, additional research needs to be completed for the development of a formal
protocol but the intention of this current protocol is to provide a temporary guideline
for audiologists and graduate students.
Study Limitations
A number of study limitations were identified throughout this research study.
The majority of the respondents were enrolled in graduate school at the time they
completed the survey. Potentially, a larger focus of practicing audiologists would have
provided a more dynamic perspective of experiences of treating patients with SLE.
Furthermore, the survey was distributed using an electronic link. As a result, the
survey was not accessible to audiologists who rarely use technology during their
personal time or do not have Facebook. It is anticipated that more respondents would
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have been reached if letters with the survey link were handed out in person at
audiology conferences.
Other limitations are in relation to the structure of the survey. Noted in the
open comments section at the end of the survey, the concept of not providing an “I
don’t know” option was mentioned. During the development of the survey, having this
option was contemplated. It was concluded to have a closed set of questions in order
to determine what most likely action they would take. Bearing in mind that this is a
topic just being integrated into the field of audiology, providing an “I don’t know”
option would not have captured what direction the respondent was leaning towards. As
a result, it may have prevented participants from fully participating in the survey and
leaving the survey incomplete. Additionally, the question “are you familiar with the
autoimmune disease by the name of systemic lupus erythematosus?” may have
deterred respondents who were not confident on the subject area. Ideally, the survey
would have indicated “we are still interested in your survey responses.”
It would have been beneficial to clarify in the survey that SLE is commonly
referred to as simply lupus. While there are multiple types of lupus, such as discoid
lupus, there are higher rates of SLE and as a result is what is typically being referred
to when the term lupus is used.
Future Research
This research study is the first known study of a qualitative design addressing
how audiologists and audiology graduate students provide care to patients with SLE.
Additional research should identify which medical or audiological clinics have a
clinical protocol and gain additional information regarding the actual administration of
audiologic care to SLE patients. It may be feasible to mine the diagnostic
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(international classification of diseases) and audiological procedure (current
procedural terminology) codes submitted to third-party payers for a better sense of
what care is being provided and the timeline for evaluations. Lastly, it might be
informative to survey patients with SLE regarding their audiological care and
experiences. Faculty surveys regarding audiology curriculums and course syllabi
might also provide a clearer picture regarding the inclusion of SLE as an educational
topic in graduate audiology training programs. The information provided in
Appendices E and F is also beneficial for integration into coursework.
Conclusion
This sample comprised of audiology graduate students and licensed
audiologists has provided a snapshot of the general approaches these two groups are
implementing in the audiologic care of patients with SLE. This study has identified
that new and experienced audiologists need more information and resources in order
to provide appropriate care. The current status of both groups is that there is a general
awareness of the disease but a limited degree of confidence in providing care. These
outcomes highlight the opportunities to develop a clinical and diagnostic protocol, to
develop additional trainings, and the need to have this topic integrated into current
graduate school courses. With the recent publications of SLE prevalence in the United
States clarifying how patient denizens have this disease, it has become clearer that
there is a likelihood that an audiologist will provide care to this population group
during their career providing direct-patient care.
This study has underlined the opportunity for a group of professionals to work
on a peer-reviewed clinical protocol. Further research should identify the appropriate
actions an audiologist must complete in order to ensure that sufficient long-term
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audiologic care can be provided to patients diagnosed with SLE. The need for
standardized care and trained audiologists is critical for patients with SLE.
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Question

Correct answer

How susceptible is a patient with systemic lupus
erythematosus to hearing loss?

Moderate to high
susceptibility

What type of hearing loss is commonly associated
with hearing loss from SLE autoimmune responses?

Sensory & Neural

For patients with SLE, does the hearing loss tend to
be bilateral or unilateral?

More so bilateral, but
unilateral has been reported

Do you believe that the duration of SLE and the
degree of hearing loss are correlated? (e.g., the longer
a person has had SLE, the poorer the hearing

Yes

Can SLE patients experience vertigo that is attributed
to the presence of the autoimmune disease?

Yes

SLE is thought to arise in patients from which of the
following factors:

Both genetic and
environmental factors

The following medications are used in the treatment
Hydroxychloroquine
of SLE. Based on your knowledge, which ones can be
ototoxic, if any? Selected choice.
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Name of the Group

Lupus Foundation of
America
https://www.lupus.org/

Molly's Fund Fighting
Lupus
https://kaleidoscopefightingl
upus.org/

Lupus Warriors
Private Facebook Page

Daily Strength Lupus
Group
https://www.dailystrength.or
g/group/lupus

Description

The national lupus
organization that has
the mission of
providing research
updates, opportunities
to join research trials,
and educate the
general public of the
disease.
A nonprofit group that
informs patients and
professionals of the
disease and oversees
the development of
government advocacy
events.
Provides patients and
family members
opportunities to
connect with other
lupus patients and
pose general questions
or concerns.
Online blog to become
connected with other
lupus patients and
family members

Connections
to Local
Support
Services?
Yes

Advocating
Opportunities?

No

Yes

Yes

Yes

No

No

Yes
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Case History
1. Hearing Sensitivity Characteristics
a. Have you experienced a sudden change in hearing sensitivity in one ear
or both ears?
b. When did you first notice a change in your hearing? Has it been slowly
progressive or sudden?
2. Auditory Symptoms
a. Tinnitus
1). Do you experience tinnitus in one ear or in both ears? If so,
when did this first start?
2). Over time, what has been your exposure to high-intensity
sounds in occupational and recreational environments?
b. Vertigo
1). If you experience any dizziness or imbalance, when does it
occur? Does your dizziness coincide with flare symptoms?
3. Medications
a. What medications are you currently on?
b. What is an estimated amount of time you have been taking
hydroxycholorquine (Plaquenil)?
4. Systemic Lupus Erythematosus Characteristics
a. Approximate time of diagnosis?
b. Comorbid disorders/diseases?
c. When was your last flare?
5. Identification of Medical Team
a. Rheumatologist?
b. Other professionals?
Baseline Audiometric Battery
Recommended
1. Otoscopy
2. Tympanometry
3. Acoustic reflex testing
4. Distortion Product Otoacoustic Emissions (DPOAEs)
5. Pure tone audiometry (250-8000Hz) via air conduction and bone
conduction
6. Extended high-frequency audiometry (EHFA) following SRO protocol
7. Speech recognition threshold (SRT) testing
8. Word recognition (WRS) testing
Case Dependent
1. If experiencing vertigo symptoms, possibly an VNG
2. Tinnitus matching protocol if tinnitus is reported
Monitoring Schedule
1. Consider every six months if the patient has a comorbid autoimmune disease
2. Annual hearing with counseling that emphasizes that if a sudden hearing loss is
perceived that immediate follow up with the primary care physician and
rheumatologist is crucial
3. Consider contacting the rheumatologist to determine monitoring schedule
Additional Considerations
1. Do additional referrals need to be made (ENT, otologist, neurologist)?
2. What releases of information need to be completed?

